Found 165 matching trials
SGLT2 Inhibitors in Geographic Atrophy PHASE2 AMD is a leading cause of blindness in individuals over 50 years old, with ...
Show More Location
Washington University
Learn More & Join Trial
Evaluation of Changes in Pancreatic Fat Content Using Advanced MR Sequences in Diabetics on Dapagliflozin Therapy PHASE4 The study aimed to assess changes in pancreatic fat content in people with ...
Show More Location
Deptt of Endocrinology
Learn More & Join Trial
IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency PHASE3 Background. Treatment with intravenous iron has been shown to improve sympt...
Show More Location
Hospital de Clínicas de Porto Alegre
Learn More & Join Trial
Effects Dapagliflozin on Inflammatory Markers Erythropoiesis and Iron Metabolism in Patients With Type 2 Diabetes and CKD PHASE3 the effect of Dapagliflozin on erythropoiesis, iron metabolism and inflamma...
Show More Location
Multiple Locations
Learn More & Join Trial
Dapagliflozin in Type 1 Diabetes PHASE4 Dapagliflozin is a highly selective, reversible and potent inhibitor of the...
Show More Location
Medical University Innsbruck, Department of Internal Medicine I
Learn More & Join Trial
PREVENTion With Sglt-2 Inhibition of Acute Kidney Injury in Intensive Care PHASE3 Background Acute Kidney Injury (AKI) is a potentially life-threatening cond...
Show More Learn More & Join Trial
A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone PHASE3 The purpose of this clinical research study is to learn if BMS-512148 (Dapa...
Show More Location
Local Institution
Learn More & Join Trial
SGLT2 Inhibitors in Non-Diabetic CKD: Effects on Vascular Calcification and Anemia PHASE3 The goal of this clinical trial is to learn if the drug dapagliflozin (an S...
Show More Location
Urology and Nephrology Center, Mansoura University
Learn More & Join Trial
Dapagliflozin Effects on Cardiometabolic Outcomes in Patients With an Acute Heart Attack. PHASE3 This study will evaluate the effect of dapagliflozin versus placebo, given ...
Show More Learn More & Join Trial
Exploratory Study to Investigate the Effect of Dapagliflozin and Exenatide Combined on Body Weight PHASE2 Obesity is a medical condition which increases the risk of other diseases, ...
Show More Location
Dept of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University and Section for Diabetes and Endocrinology at the Uppsala University Hospital
Learn More & Join Trial